Glycosaminoglycans mimetics potentiate the clonogenicity, proliferation, migration and differentiation properties of rat mesenchymal stem cells

Stem Cell Research

Volumn 8, Issue 2, 2012, Pages 180-192

  Frescaline, Guilhem ^a,b   Bouderlique, Thibault ^a,b   Huynh, Minh Bao ^a,b   Papy Garcia, Dulce ^a,b   Courty, José ^a,b   Albanese, Patricia ^a,b  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b CRRET Laboratory EAC 7149 ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ALKALINE PHOSPHATASE; CD11B ANTIGEN; CD31 ANTIGEN; CD45 ANTIGEN; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GLYCOSAMINOGLYCAN; INTERCELLULAR ADHESION MOLECULE 1; OTR4120; THY 1 ANTIGEN; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CLONOGENESIS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ADIPOGENESIS; ANIMALS; BIOLOGICAL MARKERS; CATTLE; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CLONE CELLS; FIBROBLAST GROWTH FACTOR 2; FLOW CYTOMETRY; GLYCOSAMINOGLYCANS; HEPARIN; HUMANS; MALE; MESENCHYMAL STEM CELLS; OSTEOGENESIS; PHENOTYPE; RATS; RATS, WISTAR;

RATTUS;

EID: 84856078118     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2011.09.005     Document Type: Article

References (54)

1. Albanese P., Caruelle D., Frescaline G., Delbe J., Petit-Cocault L., Huet E., Charnaux N., Uzan G., Papy-Garcia D., Courty J. Glycosaminoglycan mimetics-induced mobilization of hematopoietic progenitors and stem cells into mouse peripheral blood: structure/function insights. Exp. Hematol. 2009, 37:1072-1083.
2. Bi Y., Nielsen K.L., Kilts T.M., Yoon A., A.K.M, Wimer H.F., Greenfield E.M., Heegaard A.M., Young M.F. Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts. Bone 2006, 38:778-786.
3. Blanquaert F., Saffar J.L., Colombier M.L., Carpentier G., Barritault D., Caruelle J.P. Heparan-like molecules induce the repair of skull defects. Bone 1995, 17:499-506.
4. Blanquaert F., Barritault D., Caruelle J.P. Effects of heparan-like polymers associated with growth factors on osteoblast proliferation and phenotype expression. J. Biomed. Mater. Res. 1999, 44:63-72.
5. Chaudhary L.R., Hofmeister A.M., Hruska K.A. Differential growth factor control of bone formation through osteoprogenitor differentiation. Bone 2004, 34:402-411.
6. Colombier M.L., Lafont J., Blanquaert F., Caruelle J.P., Barritault D., Saffar J.L. A single low dose of RGTA, a new healing agent, hastens wound maturation and enhances bone deposition in rat craniotomy defects. Cells Tissues Organs 1999, 164:131-140.
7. Cool S.M., Nurcombe V. The osteoblast-heparan sulfate axis: control of the bone cell lineage. Int. J. Biochem. Cell Biol. 2005, 37:1739-1745.
8. Courty J., Dauchel M.C., Caruelle D., Perderiset M., Barritault D. Mitogenic properties of a new endothelial cell growth factor related to pleiotrophin. Biochem. Biophys. Res. Commun. 1991, 180:145-151.
9. Desgranges P., Barritault D., Caruelle J.P., Tardieu M. Transmural endothelialization of vascular prostheses is regulated in vitro by Fibroblast Growth Factor 2 and heparan-like molecule. Int. J. Artif. Organs 1997, 20:589-598.
10. Dombrowski C., Song S.J., Chuan P., Lim X., Susanto E., Sawyer A.A., Woodruff M.A., Hutmacher D.W., Nurcombe V., Cool S.M. Heparan sulfate mediates the proliferation and differentiation of rat mesenchymal stem cells. Stem Cells Dev. 2009, 18:661-670.
11. Escartin Q., Lallam-Laroye C., Baroukh B., Morvan F.O., Caruelle J.P., Godeau G., Barritault D., Saffar J.L. A new approach to treat tissue destruction in periodontitis with chemically modified dextran polymers. FASEB J. 2003, 17:644-651.
12. Friedl A., Chang Z., Tierney A., Rapraeger A.C. Differential binding of fibroblast growth factor-2 and -7 to basement membrane heparan sulfate: comparison of normal and abnormal human tissues. Am. J. Pathol. 1997, 150:1443-1455.
13. Gallagher J.T. Multiprotein signalling complexes: regional assembly on heparan sulphate. Biochem. Soc. Trans. 2006, 34:438-441.
14. Garcia-Filipe S., Barbier-Chassefiere V., Alexakis C., Huet E., Ledoux D., Kerros M.E., Petit E., Barritault D., Caruelle J.P., Kern P. RGTA OTR4120, a heparan sulfate mimetic, is a possible long-term active agent to heal burned skin. J. Biomed. Mater. Res. 2007, 80:75-84.
15. Goodger S.J., Robinson C.J., Murphy K.J., Gasiunas N., Harmer N.J., Blundell T.L., Pye D.A., Gallagher J.T. Evidence that heparin saccharides promote FGF2 mitogenesis through two distinct mechanisms. J. Biol. Chem. 2008, 283:13001-13008.
16. Gordon M.Y., Riley G.P., Watt S.M., Greaves M.F. Compartmentalization of a haematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature 1987, 326:403-405.
17. Guimond S.E., Turnbull J.E. Fibroblast growth factor receptor signalling is dictated by specific heparan sulphate saccharides. Curr. Biol. 1999, 9:1343-1346.
18. Habuchi H., Habuchi O., Kimata K. Sulfation pattern in glycosaminoglycan: does it have a code?. Glycoconj. J. 2004, 21:47-52.
19. Hanada K., Dennis J.E., Caplan A.I. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J. Bone Miner. Res. 1997, 12:1606-1614.
20. Handel T.M., Johnson Z., Crown S.E., Lau E.K., Proudfoot A.E. Regulation of protein function by glycosaminoglycans-as exemplified by chemokines. Annu. Rev. Biochem. 2005, 74:385-410.
21. Jackson R.A., Nurcombe V., Cool S.M. Coordinated fibroblast growth factor and heparan sulfate regulation of osteogenesis. Gene 2006, 379:79-91.
22. Jackson R.A., Murali S., van Wijnen A.J., Stein G.S., Nurcombe V., Cool S.M. Heparan sulfate regulates the anabolic activity of MC3T3-E1 preosteoblast cells by induction of Runx2. J. Cell. Physiol. 2007, 210:38-50.
23. Khan S.A., Nelson M.S., Pan C., Gaffney P.M., Gupta P. Endogenous heparan sulfate and heparin modulate bone morphogenetic protein-4 signaling and activity. Am. J. Physiol. 2008, 294:C1387-C1397.
24. Kotev-Emeth S., Savion N., Pri-chen S., Pitaru S. Effect of maturation on the osteogenic response of cultured stromal bone marrow cells to basic fibroblast growth factor. Bone 2000, 27:777-783.
25. Lafont J., Baroukh B., Berdal A., Colombier M.L., Barritault D., Caruelle J.P., Saffar J.L. RGTA11, a new healing agent, triggers developmental events during healing of craniotomy defects in adult rats. Growth Factors 1998, 16:23-38.
26. Lafont J., Blanquaert F., Colombier M.L., Barritault D., Carueelle J.P., Saffar J.L. Kinetic study of early regenerative effects of RGTA11, a heparan sulfate mimetic, in rat craniotomy defects. Calcif. Tissue Int. 2004, 75:517-525.
27. Ling L., Murali S., Dombrowski C., Haupt L.M., Stein G.S., van Wijnen A.J., Nurcombe V., Cool S.M. Sulfated glycosaminoglycans mediate the effects of FGF2 on the osteogenic potential of rat calvarial osteoprogenitor cells. J. Cell. Physiol. 2006, 209:811-825.
28. Manton K.J., Leong D.F., Cool S.M., Nurcombe V. Disruption of heparan and chondroitin sulfate signaling enhances mesenchymal stem cell-derived osteogenic differentiation via bone morphogenetic protein signaling pathways. Stem Cells 2007, 25:2845-2854.
29. Martin I., Muraglia A., Campanile G., Cancedda R., Quarto R. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 1997, 138:4456-4462.
30. Meddahi A., Lemdjabar H., Caruelle J.P., Barritault D., Hornebeck W. FGF protection and inhibition of human neutrophil elastase by carboxymethyl benzylamide sulfonate dextran derivatives. Int. J. Biol. Macromol. 1996, 18:141-145.
31. Meddahi A., Bree F., Papy-Garcia D., Gautron J., Barritault D., Caruelle J.P. Pharmacological studies of RGTA(11), a heparan sulfate mimetic polymer, efficient on muscle regeneration. J. Biomed. Mater. Res. 2002, 62:525-531.
32. Merry C.L., Gallagher J.T. New insights into heparan sulphate biosynthesis from the study of mutant mice. Biochem. Soc. Symp. 2002, 47-57.
33. Molteni A., Modrowski D., Hott M., Marie P.J. Alterations of matrix- and cell-associated proteoglycans inhibit osteogenesis and growth response to fibroblast growth factor-2 in cultured rat mandibular condyle and calvaria. Cell Tissue Res. 1999, 295:523-536.
34. Montero A., Okada Y., Tomita M., Ito M., Tsurukami H., Nakamura T., Doetschman T., Coffin J.D., Hurley M.M. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J. Clin. Invest. 2000, 105:1085-1093.
35. Muller B., Prante C., Gastens M., Kuhn J., Kleesiek K., Gotting C. Increased levels of xylosyltransferase I correlate with the mineralization of the extracellular matrix during osteogenic differentiation of mesenchymal stem cells. Matrix Biol. 2008, 27:139-149.
36. Navre M., Ringold G.M. Differential effects of fibroblast growth factor and tumor promoters on the initiation and maintenance of adipocyte differentiation. J. Cell Biol. 1989, 109:1857-1863.
37. Neubauer M., Fischbach C., Bauer-Kreisel P., Lieb E., Hacker M., Tessmar J., Schulz M.B., Goepferich A., Blunk T. Basic fibroblast growth factor enhances PPARgamma ligand-induced adipogenesis of mesenchymal stem cells. FEBS Lett. 2004, 577:277-283.
38. Noff D., Pitaru S., Savion N. Basic fibroblast growth factor enhances the capacity of bone marrow cells to form bone-like nodules in vitro. FEBS Lett. 1989, 250:619-621.
39. Nurcombe V., Goh F.J., Haupt L.M., Murali S., Cool S.M. Temporal and functional changes in glycosaminoglycan expression during osteogenesis. J. Mol. Histol. 2007, 38:469-481.
40. Ostrovsky O., Berman B., Gallagher J., Mulloy B., Fernig D.G., Delehedde M., Ron D. Differential effects of heparin saccharides on the formation of specific fibroblast growth factor (FGF) and FGF receptor complexes. J. Biol. Chem. 2002, 277:2444-2453.
41. Papy-Garcia D., Barbier-Chassefiere V., Rouet V., Kerros M., Klochendler C., Tournaire M., Barritault D., Caruelle J., Petit E. Nondegradative sulfation of polysaccharides. Synthesis and structure characterization of biologically active heparan sulfate mimetics. Macromolecules 2005, 38:4647-4654.
42. Pitaru S., Kotev-Emeth S., Noff D., Kaffuler S., Savion N. Effect of basic fibroblast growth factor on the growth and differentiation of adult stromal bone marrow cells: enhanced development of mineralized bone-like tissue in culture. J. Bone Miner. Res. 1993, 8:919-929.
43. Ponte A.L., Marais E., Gallay N., Langonne A., Delorme B., Herault O., Charbord P., Domenech J. The in vitro migration capacity of human bone marrow mesenchymal stem cells: comparison of chemokine and growth factor chemotactic activities. Stem Cells 2007, 25:1737-1745.
44. Pye D.A., Vives R.R., Turnbull J.E., Hyde P., Gallagher J.T. Heparan sulfate oligosaccharides require 6-O-sulfation for promotion of basic fibroblast growth factor mitogenic activity. J. Biol. Chem. 1998, 273:22936-22942.
45. Quarto N., Longaker M.T. Differential expression of specific FGF ligands and receptor isoforms during osteogenic differentiation of mouse Adipose-derived Stem Cells (mASCs) recapitulates the in vivo osteogenic pattern. Gene 2008, 424:130-140.
46. Raucci A., Bellosta P., Grassi R., Basilico C., Mansukhani A. Osteoblast proliferation or differentiation is regulated by relative strengths of opposing signaling pathways. J. Cell. Physiol. 2008, 215:442-451.
47. Rochefort G.Y., Delorme B., Lopez A., Herault O., Bonnet P., Charbord P., Eder V., Domenech J. Multipotential mesenchymal stem cells are mobilized into peripheral blood by hypoxia. Stem Cells 2006, 24:2202-2208.
48. Rouet V., Hamma-Kourbali Y., Petit E., Panagopoulou P., Katsoris P., Barritault D., Caruelle J.P., Courty J. A synthetic glycosaminoglycan mimetic binds vascular endothelial growth factor and modulates angiogenesis. J. Biol. Chem. 2005, 280:32792-32800.
49. Rozen S., Skaletsky H. Primer 3 on the WWW for general users and for biologist programmers. Methods Mol. Biol. 2000, 132:365-386.
50. Schenauer M.R., Yu Y., Sweeney M.D., Leary J.A. CCR2 chemokines bind selectively to acetylated heparan sulfate octasaccharides. J. Biol. Chem. 2007, 282:25182-25188.
51. Stich S., Loch A., Leinhase I., Neumann K., Kaps C., Sittinger M., Ringe J. Human periosteum-derived progenitor cells express distinct chemokine receptors and migrate upon stimulation with CCL2, CCL25, CXCL8, CXCL12, and CXCL13. Eur. J. Cell Biol. 2008, 87:365-376.
52. Turnbull J.E., Fernig D.G., Ke Y., Wilkinson M.C., Gallagher J.T. Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. J. Biol. Chem. 1992, 267:10337-10341.
53. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3. (RESEARCH0034).
54. Xiao L., Sobue T., Esliger A., Kronenberg M.S., Coffin J.D., Doetschman T., Hurley M.M. Disruption of the Fgf2 gene activates the adipogenic and suppresses the osteogenic program in mesenchymal marrow stromal stem cells. Bone 2010, 47:360-370.